Discontinued — last reported Q4 '19
Business Segments · D&A
Covance Drug Development — D&A
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2019Feb 28, 2020
Rolls up toD&A
How to read this metric
High levels relative to revenue may indicate a capital-intensive business model or significant recent acquisition activity requiring asset amortization.
Detailed definition
The systematic allocation of the cost of tangible and intangible assets over their useful lives within the drug developm...
Peer comparison
Standard operating expense across all capital-intensive industries; essential for calculating EBITDA.
Metric ID:
lh_segment_covance_drug_development_depreciation_depletion_and_amortizationSimilar Metrics at Other Companies
Frequently Asked Questions
- What does covance drug development — d&a mean?
- The non-cash expense representing the wear and tear or expiration of the company's assets over time.